Sanofi Enters a ~$1.84B Global License Agreement with Earendil Labs for HXN-1002 & HXN-1003
Shots: Earendil Labs has granted Sanofi exclusive global rights to develop HXN-100...
Oak Hill Bio Enters an Exclusive Licensing Agreement with Roche for Rugonersen
Shots: Oak Hill Bio has entered into an exclusive license agreement with Roche to...
Biocon Biologics and Regeneron Settle over Yesafili’s (Biosimilar, Eylea) US Launch
Shots: Biocon Biologics & Regeneron have entered into a settlement & licen...
Merck Signs a ~$493M Deal with Cyprumed to Develop Oral Peptide Therapeutics
Shots: Cyprumed & Merck have entered into a non-exclusive license & option...
Cue Biopharma Collaborates with Boehringer Ingelheim to Develop B cell-Targeting Bispecifics for Autoimmune and Inflammatory Disea...
Shots: BI & Cue Biopharma have entered into a multi-year strategic research &a...
Astellas Collaborates with Chromatin Bioscience to Develop Cell-Selective Synthetic Promoters
Shots: Astellas has entered into a collaboration agreement with Chromatin Bioscien...
